Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

generic medicines

  1. Home>
  2. News>
  3. generic medicines>
  4. Page 18

CDSCO to Launch Digital Drug Regulatory Platform in 18 Months

  • Post published:August 5, 2026
  • Post category:News

India's central drug regulator is betting on digital technology to speed up drug approvals and sharpen oversight. The Central Drugs Standard Control Organisation (CDSCO) has announced plans to launch the…

Continue Reading CDSCO to Launch Digital Drug Regulatory Platform in 18 Months

Understanding Drug Patents and Generic Market-Entry Timing: A 2026 Buyer’s Guide

  • Post published:August 4, 2026
  • Post category:Knowledge

India is widely known as the "pharmacy of the world," but not every medicine can be bought as a cheap generic on day one. If a drug is still under…

Continue Reading Understanding Drug Patents and Generic Market-Entry Timing: A 2026 Buyer’s Guide

Dr. Reddy’s Wins US FDA Approval for Rituximab Biosimilar

  • Post published:August 3, 2026
  • Post category:News

Indian drugmakers are pushing deeper into the United States biologics market. Dr. Reddy's is reported by multiple financial media outlets in early August 2026 to have secured approval from the…

Continue Reading Dr. Reddy’s Wins US FDA Approval for Rituximab Biosimilar

Understanding the Indian Pharmacopoeia 2026: Drug Quality Standards for Buyers

  • Post published:August 2, 2026
  • Post category:Knowledge

India supplies roughly one-fifth to one-third of the world's generic medicines, yet the documents that define what "quality" means for every tablet and vial made in India remain unfamiliar to…

Continue Reading Understanding the Indian Pharmacopoeia 2026: Drug Quality Standards for Buyers
  • Go to the previous page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 31
  • Go to the next page

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
    November 14, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide
  • India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve